BOLINGBROOK, Ill., Dec. 17, 2024 /PRNewswire/ -- ATI Physical Therapy, Inc. (OTCMKTS: ATIP) ("ATI" or the "Company"), a nationally recognized outpatient physical therapy provider in the United States, announced today that it is commencing a tender offer to purchase for cash up to 1,650,000 shares of its Class A common stock (the "Shares") at a purchase price of $2.85 per Share.The number of Shares proposed to be purchased in the tender offer represents approximately 37.4% of the Company's currently outstand ...

BOLINGBROOK, Ill., Dec. 3, 2024 /PRNewswire/ -- ATI Physical Therapy, Inc. (NYSE: ATIP) ("ATI" or the "Company"), a nationally recognized outpatient physical therapy provider in the United States, today announced that it received notification from the New York Stock Exchange ("NYSE") indicating that the Company's Class A common stock will be delisted, and trading of its Class A common stock on the NYSE was suspended, after market close on December 3, 2024. The Company today also announced that it is current ...

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:ATI Inc. (ATI) is a specialty manufacturing company. The Zacks Consensus Estimate for its current year earnings has been revised 5.2% downward over the last 60 days.Bally's Corporation (BALY) is a casino entertainment company. The Zacks Consensus Estimate for its current year earnings has been revised 85.7% downward over the last 60 days.Coca-Cola FEMSA, S.A.B. de C.V. (KOF) is a franchise bottling company.The Zacks Consensus Estimate ...

Overwhelming shareholder support in favour of take-private transaction with Aditxt Studies presented at IDWeek 2024™ demonstrate ATI-1701 provides full protection against lethal tularemia in animal models after one year Alignment with U.S. Food and Drug Administration on development requirements for ATI-1801 NDA Submission HALIFAX, Nova Scotia, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX:APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug develo ...

The Achievement Continues the Company's Streak in Earning the Rating Annually Since the Program Debuted in 2019BOLINGBROOK, Ill., Nov. 13, 2024 /PRNewswire/ -- ATI Physical Therapy ("ATI" or the "Company") today has again earned the "Exceptional" rating from the Center for Medicare and Medicaid Services' (CMS) Merit-Based Incentive Payment System (MIPS) for quality patient care. ATI received the exceptional rating for the fifth consecutive year, every year since the program's inception for physical therapy ...

Sharpens focus on strategic aerospace and defense markets, streamlines operations DALLAS, Nov. 6, 2024 /PRNewswire/ -- ATI Inc. (NYSE: ATI) announced it completed the sale of its precision rolled strip operations in New Bedford, Massachusetts and Remscheid, Germany to Ulbrich Stainless Steels and Special Metals, Inc. (Ulbrich)."With this divestiture, ATI sharpens its focus on providing our aerospace and defense customers with the titanium, nickel, and alloyed products that are rolled, melted and/or finished ...

BOLINGBROOK, Ill., Nov. 4, 2024 /PRNewswire/ -- ATI Physical Therapy, Inc. (NYSE: ATIP) ("ATI" or the "Company"), a nationally recognized outpatient physical therapy provider in the United States, today reported financial results for the third quarter ended September 30, 2024."Our consistent efforts to provide access to quality treatment for our patients underscores our strong operational performance in the third quarter," said Sharon Vitti, Chief Executive Officer of ATI. "We continue to see year-over-year ...

Demonstrated safety and efficacy across multiple Phase 2 and Phase 3 studies Appili provides update on Aditxt transaction and encourages shareholders to vote their shares as soon as possible for the November 6, 2024 shareholders meeting HALIFAX, Nova Scotia, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced that the U.S ...

ATI Inc. (ATI) recorded a third-quarter 2024 profit of $82.7 million or 57 cents per share compared with the year-ago quarter's $90.2 million or 62 cents. ATI posted adjusted earnings of 60 cents, down 6% from the yearago quarter figure of 64 cents. The bottom line missed the Zacks Consensus Estimate of 66 cents. Find the latest EPS estimates and surprises on Zacks Earnings Calendar. The company's third-quarter net sales were $1,051.2 million, missing the Zacks Consensus Estimate of $1,127.4 million. Net sa ...

ATI Inc (NYSE:ATI) Q3 2024 Results Conference Call October 29, 2024 8:30 AM ET Company Participants David Weston - Vice President of Investor Relations Kim Fields - President, CEO & Director Don Newman - Executive VP of Finance & CFO Conference Call Participants Richard Safran - Seaport Research Partners Andre Madrid - BTIG David Strauss - Barclays Phil Gibbs - KeyBanc Capital Markets Timna Tanners - Wolfe Research Seth Seifman - JPMorgan Scott Deuschle - Deutsche Bank Operator Hello, everyone, and welcome ...